Hong Kong
· Delayed Price · Currency is HKD Cryofocus Medtech (Shanghai) Company Description
Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally invasive interventional cryotherapy products in the People’s Republic of China.
The company develops products in two areas: vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases.
Its products include the Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; the Gastric Cryoablation System, a self-developed cryoablation system indicated for performing cryoablation on gastric tumors to treat gastric cancer; the Esophageal Cryospray System, for intermediate to advanced esophagus cancer; the pulmonary nodule localization needle for CT-guided localization of lung nodules; the endoscopic clip for anastomosis for the closure of soft tissue in the digestive tract; the laparoscopic single-port multichannel access platform for laparoscopic surgery; the Atrial Fibrillation Pulsed Field Ablation System, for paroxysmal atrial fibrillation; the Anti-Gastroesophageal Reflux System, for gastroesophageal reflux disease; and other non-cryotherapy products.
The company’s products also comprise wound retractors for small incision surgery and minimally invasive surgery; ureteral dilation balloon catheters for ureteral stricture; laparoscopic biopsy bags for biopsy; and laparoscopic surgical instruments for laparoscopy applications.
The company was incorporated in 2013 and is based in Shanghai, the People’s Republic of China.
| Country | China |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 276 |
| CEO | Jun Zhu |
Contact Details
Address: Building 15 Shanghai, 200120 China | |
| Phone | 86 21 2097 7850 |
| Website | cryofocus.com |
Stock Details
| Ticker Symbol | 6922 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Kejian Li | Executive Chairman of the Board |
| Jun Zhu | GM and Executive Director |
| Wei Liu | Chief Financial Officer, Joint Company Secretary and Executive Director |
| Dr. Kuiwen Zhao | Technical Director and Research & Development Manager |
| Dr. Jihong Qu | Chief Medical Officer |
| Zhimin Chen | Executive Vice President of Ningbo SensCure |
| Wai Yan Leung | Joint Company Secretay |
| Yuepeng Diao | Deputy Vice President |